Our data also indicated that PS341 treatment largely decreased the expression of both MMP2 and MMP9 in HCC and CRC cells (Fig. 2e), thus restricting the migration capacities of these two tumor types. The gene discussed is MMP9; the disease is colorectal carcinoma.